What Ekso Bionics does

Ekso Bionics is a publicly-traded (NASDAQ: EKSO) medical device company founded in 2005 and headquartered in the San Rafael/Richmond, California area that develops powered lower-limb and upper-body exoskeletons for clinical rehabilitation and industrial workplace applications. The core medical product line consists of the EksoNR robotic exoskeleton (FDA-cleared for stroke, acquired brain injury, multiple sclerosis, and spinal cord injury, with proprietary GaitCoach real-time gait-feedback software), the Ekso Indego Therapy clinical gait-training device, and the Ekso Indego Personal personal-use exoskeleton for individuals with T3-L5 spinal cord injury. The company also sells the Ekso EVO upper-body industrial exoskeleton for overhead work and lifting, and holds exclusive U.S. distribution rights to MediTouch's BalanceTutor perturbation treadmill for balance and fall-prevention training.

Revenue is generated primarily through capital-equipment hardware sales to rehabilitation hospitals and clinics (via a direct enterprise field-sales motion and a 500+ center certified network globally), supplemented by clinical training and technical support services and by personal-device sales fulfilled through the U.S. Department of Veterans Affairs and Medicare reimbursement pathways established under the brace benefit category as of April 2024. Industrial products are sold directly to employers in construction, manufacturing, and logistics, while the MediTouch BalanceTutor provides additional distribution-margin revenue. The company has been unprofitable, has run four dilutive equity raises totaling roughly $20M between January 2024 and January 2026, and in December 2025 announced — closing in May 2026 — a merger of Applied Digital's cloud-computing business into the public entity to form ChronoScale Corporation, with Applied Digital retaining approximately 97% ownership.

Name

Ekso Bionics

Legal name

Ekso Bionics Europe GmbH & Ekso Bionics USA

Website

https://eksobionics.com

Company type

Public

Founded year

2005

Operating status

Operating

Headcount range

101–250 employees

Short description

Ekso Bionics develops powered exoskeletons for clinical neurorehabilitation (EksoNR, Indego Therapy, Indego Personal) and industrial upper-body support (Ekso EVO), selling to hospitals, the VA, Medicare-eligible individuals with spinal cord injury, and industrial employers.

Ownership category

akta.pro rank

Product category

Medical Rehabilitation Robotics

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Sports & Active Rehabilitation Devices (Adaptive Sports Mobility, Performance Prosthetics) (HLAHAMAJ)

akta.pro secondary industries

Prosthetics/Orthotics Rehab & Amputee Rehabilitation (HSADAIAN), Compression Therapy & Lymphedema DME (Garments, Pneumatic Pumps) (HLAHAMAH)

Keywords

• Wearable robotic exoskeletons
• Medical rehabilitation devices
• Industrial exoskeleton systems
• Neurorehabilitation robotics
• Gait training equipment

Headquarters

HQ city

San Rafael

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Exoskeleton Hardware Sales: Sale of EksoNR, Ekso Indego Therapy, and Ekso Indego Personal exoskeleton devices to rehabilitation centers, hospitals, and individuals. Q3 2025 revenue was $4.2 million.
2. Clinical Training and Support Services: Training programs for clinical staff, certified Ekso Indego Specialist certification, and ongoing technical support for deployed devices.
3. Veterans Affairs (VA) Device Coverage: VA policy allows Ekso Indego Personal to be issued to qualified veterans at no cost to the veteran. Reimbursement from government healthcare programs.
4. Medicare Personal Exoskeleton Coverage: As of April 2024, CMS established Medicare payment level for personal exoskeletons confirming coverage within brace benefit category for eligible individuals.
5. Distribution Revenue (BalanceTutor): Exclusive U.S. distributor of MediTouch's BalanceTutor rehabilitation system, generating revenue from sales and distribution of the perturbation treadmill system.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels7 records

Core offering

Ekso Bionics designs, develops, manufactures, and sells wearable bionic exoskeletons for medical rehabilitation and industrial workplace use. Its medical line (EksoNR, Ekso Indego Therapy, Ekso Indego Personal) provides powered lower-limb assistance for patients recovering from stroke, acquired brain injury, multiple sclerosis, and spinal cord injury, while the Ekso EVO upper-body exoskeleton serves industrial employers seeking to reduce workplace injuries from overhead work and lifting. The company also exclusively distributes the MediTouch BalanceTutor perturbation treadmill in the United States.

Product overview

Ekso Bionics offers a portfolio of wearable bionic exoskeletons for both medical/rehabilitation and industrial applications. The medical portfolio includes EksoNR (rehabilitation exoskeleton FDA-cleared for stroke, ABI, MS, and SCI with GaitCoach software), Ekso Indego Therapy (clinical gait training), and Ekso Indego Personal (home/community use for SCI patients T3-L5). The industrial line features Ekso EVO (upper-body workplace exoskeleton). The company also distributes MediTouch's BalanceTutor perturbation treadmill and provides cloud analytics via EksoPulse. Past products include EksoVest and the military HULC exoskeleton. All products share core exoskeleton technology with modular designs, sensors, and real-time control systems.

Differentiator

Problem solved

Functional benefit

Brands

• Ekso Indego Personal: A powered lower limb exoskeleton for individuals with spinal cord injuries (T3-L5) enabling independent walking at home and in the community. Weighs 31 lbs (14 kg), FDA-cleared, available through Medicare.
• Ekso Indego Therapy
• EksoNR
• Ekso EVO
• BalanceTutor

Products and services

• EksoNR A robotic exoskeleton for rehabilitation settings, FDA-cleared for stroke, acquired brain injury, multiple sclerosis (MS), and spinal cord injury (SCI). Features GaitCoach software with real-time gait deviation detection and intelligent feedback, supports over 200 published clinical articles, and enables therapists to deliver high-intensity, repetitive gait training.
• Ekso Indego Therapy An adjustable, lower-limb powered exoskeleton for clinical rehabilitation settings. Enables individualized gait therapy for patients with lower extremity weakness or paralysis from spinal cord injury or stroke, featuring a modular design and a wireless iOS application for real-time therapist controls and patient data capture.
• Ekso Indego Personal A powered lower limb exoskeleton enabling individuals with spinal cord injuries (T3-L5) to stand and walk independently at home and in the community. Features modular quick-connect components, weighs 31 lbs (14 kg), and includes a wireless iOS/Android app for real-time control and session data tracking.
• Ekso EVO An upper-body wearable industrial exoskeleton designed to increase safety, productivity, and reduce injuries to the neck, shoulder, and back. Described as the world's most lightweight, durable, assistive industrial exoskeleton with maximum degree of freedom, used for overhead work and heavy lifting in construction, manufacturing, automotive, and logistics.
• BalanceTutor An FDA-registered advanced multidirectional perturbation treadmill for rehabilitation. Engineered by MediTouch, it promotes reactive response training for improved balance using patented perturbation technology and multiple force and movement sensors. Ekso Bionics is the authorized exclusive U.S. distributor.
• AI-Enabled Rehabilitation Exoskeleton An AI-enabled rehabilitation exoskeleton developed by Ekso Bionics and launched in March 2026, reflecting the company's collaboration with NVIDIA to accelerate AI integration in wearable robotics.

Quantifiable outcome

• 1,200-step increase in walking capacity demonstrated with EksoNR exoskeleton
• +2 more outcomes

Named customers12 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered flagship and core.

• Applied Digital CorporationflagshipStrategic or Co-development Partner · 29 December 2025Applied Digital proposed business combination with EKSO Bionics to launch ChronoScale, an accelerated compute platform for AI workloads. The transaction involved spinning out Applied Digital's cloud business to merge with Ekso Bionics Holdings. Applied Digital retained ~97% ownership of the combined entity. The deal closed May 5, 2026, with ChronoScale trading under ticker CHRN.
• MediTouch Inc.coreChannel Partner/ Reseller/ Distributor · 4 December 2025Ekso Bionics became the exclusive U.S. distributor of MediTouch's BalanceTutor rehabilitation system. BalanceTutor is an FDA registered advanced multidirectional perturbation treadmill for reactive balance and fall-prevention training. The partnership expands Ekso's clinical rehabilitation portfolio to address balance training alongside existing gait exoskeleton offerings.
• NVIDIAcoreTechnology or Integration · 1 May 2025Ekso Bionics Holdings collaborated with NVIDIA in May 2025 to accelerate AI integration in wearable robotics. The collaboration focuses on advancing AI capabilities in exoskeleton technology, leveraging NVIDIA's computing platforms for enhanced robotics performance.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Hocoma (DIH Medical): Hocoma — now part of DIH Medical — is a global leader in robotic rehabilitation with the Lokomat treadmill-based gait trainer and Armeo upper-limb devices. It competes head-to-head with EksoNR in clinical neurorehabilitation settings and is the most-established player in robotic gait training.
• Bionik Laboratories: Bionik Laboratories produces robotic rehabilitation devices including the InMotion ARM and InMOTO WELL, focused on upper-limb and gait therapy in clinical settings. It is a smaller, sub-scale pure-play competitor in the same rehabilitation robotics category as Ekso Bionics.
• ReWalk Robotics: ReWalk is the closest direct competitor to Ekso Bionics, also producing FDA-cleared powered exoskeletons (ReWalk Personal 6.0) for spinal cord injury ambulation and a clinical rehabilitation device. Both companies target the same SCI patient population, compete for VA and CMS reimbursement pathways, and sell to overlapping rehabilitation centers.
• Sarcos Technology and Robotics: Sarcos developed the Guardian XO and other industrial exoskeletons for worker augmentation, directly competing with Ekso EVO in the industrial/workplace safety segment. Both target employers seeking to reduce musculoskeletal injuries in construction, manufacturing, and logistics.
• German Bionic: German Bionic produces the Cray X and Apogee+ connected industrial exoskeletons for logistics, construction, and manufacturing workers. It directly competes with Ekso EVO in the workplace-assistive exoskeleton market, particularly across European enterprises.
• Cyberdyne: Cyberdyne develops the HAL (Hybrid Assistive Limb) wearable cyborg exoskeleton, with both medical (SCI, stroke) and industrial applications. It directly parallels Ekso's two-segment strategy of rehabilitation and workplace exoskeletons and is a key competitor in Japan and Asia.

Broad incumbents

• Ottobock: Ottobock is a global leader in prosthetics, orthotics, and now exoskeletons (including the acquired SuitX industrial line). As a much larger, established medical-device company, it competes with Ekso across both rehabilitation and industrial exoskeleton categories with deeper resources and a global distribution network.
• Medtronic: Medtronic is a global medical-device incumbent with adjacent presence in neuromodulation, brain therapies, and rehabilitation-adjacent technologies. While not a direct exoskeleton competitor at scale, it competes for hospital neurology and rehabilitation budgets and could expand into the category.
• Abbott: Abbott is a broad medical-device and diagnostics incumbent with significant neurology and rehabilitation-adjacent product lines. As a large-cap peer in the neurorehabilitation devices market, it competes for hospital purchasing dollars and could potentially enter robotic exoskeleton therapy.

Emerging players

• MindMaze: MindMaze develops digital neurotherapeutics and AI-driven neurorehabilitation platforms for stroke and brain injury recovery. It overlaps with Ekso's ABI and stroke rehabilitation focus through a software-first approach rather than powered exoskeletons, making it a partial-overlap emerging competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtwitter.com/EksoBionics
• YouTubeyoutube.com/EksoBionics
• Facebookfacebook.com/EksoBionics
• LinkedInlinkedin.com/company/ekso-bionics
• Instagraminstagram.com/eksobionics
• TikToktiktok.com/@eksobionics

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds17 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ekso Bionics